Amanote Research

Amanote Research

    RegisterSign In

Pharmacotherapy of Hematologic Malignancies With Tipifarnib

Clinical Medicine. Therapeutics
doi 10.4137/cmt.s1097
Full Text
Open PDF
Abstract

Available in full text

Date

January 1, 2009

Authors
Ioannis KotsianidisEvangelia NakouIrene Bouchliou
Publisher

SAGE Publications


Related search

Hematologic Malignancies

Oncologist
Cancer ResearchMedicineOncology
1999English

Chylothorax in Hematologic Malignancies

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Parainfluenza Virus Infections in Children With Hematologic Malignancies

Pediatric Infectious Disease Journal
Child HealthInfectious DiseasesPediatricsPerinatologyMicrobiology
2011English

Vaccine Therapy in Hematologic Malignancies

Blood
BiochemistryImmunologyCell BiologyHematology
2018English

PET in the Management of Hematologic Malignancies

PET Clinics
MedicineNuclear MedicineRadiologyRadiationImaging
2019English

Current Role of Genetics in Hematologic Malignancies

Indian Journal of Hematology and Blood Transfusion
Hematology
2015English

Dendritic Cell Therapies for Hematologic Malignancies

Molecular Therapy - Methods and Clinical Development
Molecular MedicineGeneticsMolecular Biology
2017English

Bispecific Antibodies in the Treatment of Hematologic Malignancies

Clinical Pharmacology and Therapeutics
Pharmacology
2019English

Venous Thromboembolism in the Hematologic Malignancies

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy